Iovance Biotherapeutics Inc.

(IOVA) Trade

By |

Profile

Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient.

Contact Information

Website: www.iovance.com
Email: sarah@sternir.com
Main Phone: +1 650 260-7120
Address: 999 Skyway Road
Address 2: Suite 150
State: CA
City / Town: San Carlos
Country: USA
Postal Code: 94070

Issuer Information

Exchange: NSD
CEO: Maria Fardis
Employees: 88
NAICS: Medicinal and Botanical Manufacturing(325411)


Gathering Data... Please wait

Profile

Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient.

Contact Information

Website: www.iovance.com
Email: sarah@sternir.com
Main Phone: +1 650 260-7120
Address: 999 Skyway Road
Address 2: Suite 150
State: CA
City / Town: San Carlos
Country: USA
Postal Code: 94070

Issuer Information

Exchange: NSD
CEO: Maria Fardis
Employees: 88
NAICS: Medicinal and Botanical Manufacturing(325411)
$ 20.95 $ 0.93 (4.65%)
Last Price 20.95 Change $ 0.93 Change % 4.65 Tick N/A
Bid 20.95 Bid Size 100.00 Ask 22.19 Ask Size 100.00
Open 20.22 High 21.15 Low 20.10 Prev Close 20.02
Last Trade Volume 1.1 mi 52 Wk Hi 26.59 52 Wk Low 7.26
Market Cap 2.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 123,830,506.00 EPS (TTM) -1.30 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Martin Schroeder 1,000
Merrill A. McPeak 1,000
Last 10 Sell Shares
Sanford J. Hillsberg 1,000
Sanford J. Hillsberg 1,000
Sanford J. Hillsberg 1,000
Sanford J. Hillsberg 1,000
Sanford J. Hillsberg 1,000
Sanford J. Hillsberg 1,000
Sanford J. Hillsberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 31 31 31 31
Low Target Price Estimate 22 22 22 22
Mean Target Price Estimate 25.33 25.33 25.33 25.33
Standard Deviation 4.08 4.08 4.08 4.08
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 06/13/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 6
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1.29